SCHEMBL737510

SCHEMBL737510

CN(C(=O)[C@@H](Cc1csc2ccccc12)NC(=O)C(C)(C)N)[C@H](Cc1csc2ccccc12)NS(C)(=O)=O

nearest known ligand 0.42

Predicted protein targets (top 20)

geneUniProtsupporting neighboursconfidence
CTSL P07711 1/20 0.42
CTSS P25774 1/20 0.42
CTSK P43235 1/20 0.42
TACR1 P25103 1/20 0.40
MMP2 P08253 2/20 0.39
MMP9 P14780 2/20 0.39
MMP8 P22894 2/20 0.39
OPRM1 P35372 3/20 0.38
OPRD1 P41143 2/20 0.38
OPRK1 P41145 2/20 0.38
F10 P00742 2/20 0.38
CA1 P00915 1/20 0.37
CA2 P00918 1/20 0.37
MMP1 P03956 1/20 0.37
MMP3 P08254 1/20 0.37
MMP14 P50281 1/20 0.37
MMP25 Q9NPA2 1/20 0.37
GHSR Q92847 1/20 0.36
KLKB1 P03952 1/20 0.36
KLK1 P06870 1/20 0.36

Click a target to see other patent compounds predicted against it — the reverse direction, in place.

Similar compounds — the chemically nearest patent molecules

Nearest neighbours by Morgan-fingerprint cosine across the patent-compound collection, with each neighbour's top predicted target and the predicted targets it shares with this molecule.

Compoundsimilaritytop predictedshared targets
SCHEMBL736815 0.88 TACR1 (0.47) CTSLCTSSCTSKTACR1MMP2
SCHEMBL736819 0.87 OPRM1 (0.47) CTSLCTSSCTSKTACR1MMP2
SCHEMBL762231 0.84 CTSL (0.49) CTSLCTSSCTSKTACR1MMP2
SCHEMBL736822 0.82 OPRM1 (0.50) CTSLCTSSCTSKTACR1MMP2
SCHEMBL739137 0.80 GHSR (0.51) TACR1MMP2MMP9MMP8OPRM1
SCHEMBL736841 0.80 GHSR (0.61) TACR1MMP2MMP9MMP8OPRM1
SCHEMBL14615508 0.79 CTSL (0.52) CTSLCTSSCTSKTACR1MMP2
SCHEMBL760987 0.79 F10 (0.55) CTSLCTSSCTSKTACR1MMP2
SCHEMBL736855 0.77 GHSR (0.45) CTSLCTSSCTSKTACR1MMP2
SCHEMBL737102 0.77 GHSR (0.45) CTSLCTSSCTSKTACR1MMP2

Similarity is cosine over the 2,048-bit Morgan fingerprint (≈ Tanimoto). Identical fingerprints score 1.00.

Patent provenance — the patents this molecule appears in, and who filed them

Claimed or disclosed in 2 patents. claimed = in the patent's claims; disclosed = body only.

PatentTitleAssigneePublishedPriorityFilingCountryStatus
US-8138218-B2 Growth hormone secretagogues IPSEN PHARMA S.A.S. (FR) 2012-03-20 US disclosed
US-20090131478-A1 Growth Hormone Secretagogues IPSEN PHARMA S.A.S. (FR) 2009-05-21 US disclosed

Patent text — is the patent's own abstract consistent with the prediction?

For each of this compound's patents that has machine-readable text (1 of them — usually the abstract, not the full specification), we ask MedCPT which protein the text reads most about, and where the chemistry-predicted target lands among 4885 human targets. A high rank means the patent's own wording is consistent with the prediction — a weak, independent signal, not proof of activity.

PatentTitleText reads most aboutPredicted target · text-rank
US-20090131478-A1 Growth Hormone Secretagogues GHSR, GHRHR, GHITM CTSL 590/4885CTSS 886/4885CTSK 1894/4885

“Text reads most about” is the patent abstract's nearest protein in MedCPT space (background-debiased). Only ~1.4% of patents have machine-readable text, so most compounds won't have this panel.